Related Experiment Videos
Characterization of the capsular polysaccharide of Burkholderia (Pseudomonas) pseudomallei 304b
H Masoud1, M Ho, T Schollaardt
1Institute for Biological Sciences, National Research Council, Ottawa, Ontario, Canada.
Abstract:
Burkholderia (Pseudomonas) pseudomallei is the causative agent of melioidosis, a bacterial infection of considerable morbidity in areas of endemicity of Southeast Asia and northern Australia. Clinical isolates of B. pseudomallei have been demonstrated to produce a lipopolysaccharide (LPS) containing two separate and chemically distinct antigenic O polysaccharides against which infected patients produced antibodies. A putative capsular polysaccharide (CPS) has also been reported and is thought to be antigenically conserved based on results of serological studies with clinical B. pseudomallei isolates. In the present study, the CPS isolated from B. pseudomallei 304b from northeastern Thailand was found to have an [alpha]D of +99 degrees (water), was composed of D-galactose (D-Gal), 3-deoxy-D-manno-2-octulosonic acid (KDO), and O-acetyl 3:1:1), and was a linear unbranched polymer of repeating tetrasaccharide units having the following structure: -3)-2-O-Ac-beta-D-Galp-(1-4)-alpha-D-Galp-(1-3)-beta-D -Galp-(1-5)-beta-D-KDOp-(2-. Sera from 13 of 15 patients with different clinical manifestations of melioidosis but not normal controls recognize the CPS, which suggests that it is immunogenic and raises the possibility that it may have a role as a vaccine candidate and/or diagnostic agent.
Insights
Burkholderia pseudomallei causes melioidosis. Researchers characterized its capsular polysaccharide (CPS), finding it immunogenic in melioidosis patients, suggesting potential as a vaccine or diagnostic tool.
Area of Science:
- Microbiology and Immunology
- Bacterial Pathogenesis
- Vaccine Development
Background:
- Melioidosis, caused by Burkholderia pseudomallei, is a significant health concern in Southeast Asia and northern Australia.
- B. pseudomallei produces lipopolysaccharide (LPS) and a potentially conserved capsular polysaccharide (CPS).
- Previous serological studies indicated the capsular polysaccharide (CPS) of B. pseudomallei is antigenically conserved.
Purpose of the Study:
- To isolate and characterize the capsular polysaccharide (CPS) from Burkholderia pseudomallei.
- To determine the immunogenicity of the isolated CPS in patients with melioidosis.
- To explore the potential of CPS as a vaccine candidate or diagnostic agent.
Main Methods:
- Isolation and structural elucidation of the capsular polysaccharide (CPS) from B. pseudomallei 304b.
- Chemical composition analysis including sugar content (D-galactose, KDO) and acetylation.
- Serological testing of patient sera against the purified CPS.
Main Results:
- The CPS is a linear polymer composed of repeating tetrasaccharide units, including D-galactose and KDO.
- The structure was determined to be -3)-2-O-Ac-beta-D-Galp-(1-4)-alpha-D-Galp-(1-3)-beta-D -Galp-(1-5)-beta-D-KDOp-(2-.
- Sera from 13 out of 15 melioidosis patients recognized the CPS, while normal controls did not.
Conclusions:
- The characterized capsular polysaccharide (CPS) of B. pseudomallei is immunogenic in patients with melioidosis.
- The findings suggest that the CPS could serve as a potential vaccine candidate.
- The immunogenic nature of CPS also indicates its utility as a diagnostic agent for melioidosis.